Kevin DeGeeter Initiated (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022

Top and Current
Source: (remove) : Kevin DeGeeter
^{RSS •
JSON •
XML •
CSV}

Tue, April 19, 2022

[ Tue, Apr 19th 2022 ] - WOPRAI

Fri, October 1, 2021

[ Fri, Oct 01st 2021 ] - WOPRAI

Tue, June 29, 2021

[ Tue, Jun 29th 2021 ] - WOPRAI

Mon, March 1, 2021

[ Mon, Mar 01st 2021 ] - WOPRAI

Mon, January 11, 2021

[ Mon, Jan 11th 2021 ] - WOPRAI

Tue, January 5, 2021

[ Tue, Jan 05th 2021 ] - WOPRAI

Wed, April 8, 2020

[ Wed, Apr 08th 2020 ] - WOPRAI

Tue, January 29, 2019

[ Tue, Jan 29th 2019 ] - WOPRAI

Wed, April 12, 2017

[ Wed, Apr 12th 2017 ] - WOPRAI

Wed, January 4, 2017

[ Wed, Jan 04th 2017 ] - WOPRAI

Wed, March 4, 2015

[ Wed, Mar 04th 2015 ] - WOPRAI

^{Published on 2024-10-27 20:30:06 - WOPRAI, Kevin DeGeeter}

Kevin DeGeeter of Oppenheimer, Initiated "AN2 Therapeutics, Inc." (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022.

Kevin, nor any peers, have made any analyst calls on ANTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

N@N